← Eichor
Study identifier: NCT06984211 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Vibrometer Based Pulse Wave Analysis for Arterial Stiffness and Ischemic Heart Disease Risk Assessment

Condition: Hypertension · Ischemic Heart Disease · Valvular Heart Disease  ·  Sponsor: HJN Sverige AB/Neko Health

PhaseN/A
Planned participants8000
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

This clinical investigation will evaluate a novel contactless technology for assessing arterial stiffness and explore its potential in assessment of risk for and development of cardiovascular disease. The main aims of the study are: 1. To assess device and method performance for assessment of arterial stiffness and cardiovascular risk, on a prospective primary care cohort. 2. To see if precision may be added in CVD risk assessment through a multi-modal approach, combining data on macro- and micro-circulatory function.

This description comes directly from the study's public registry record.

Talk to the study team

Mattias Windå, MSc  ·  +46703169040  ·  mattias@nekohealth.com

Always discuss trial participation with your own doctor first.

Locations (3)

Atrium Health Care CentreStockholm, SwedenRecruiting
Neko Health Centre, RegeringsgatanStockholm, SwedenRecruiting
Neko Health Centre, SibyllegatanStockholm, SwedenRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06984211